-
Demographic Disparities in GLP-1 RA Trial Enrollment Raise Inclusivity, Validity Concerns
27 Oct 2025 18:19 GMT
… receptor agonist (RA) clinical trials for weight loss, raising concerns … .1
In 2005, exenatide (Byetta) became the first GLP-1 … from the US Food and Drug Administration. Since then, the … .1 “Inclusive and representative trial enrollment is essential to address …
-
2024 First Generic Drug Approvals
23 Oct 2025 18:33 GMT
…
Amneal EU, Limited
Byetta Injection
11/19 … without concomitant dopaminergic medications
53
216035
Riluzole Oral … treatment of erectile dysfunction
38
215570
Palbociclib Tablets
Synthon Pharmaceuticals … 0.18 mg
Indoco Remedies Limited
Lucemyra (Lofexidine) …
-
GLP-1s may be more cardioprotective than other diabetes drugs
21 Oct 2025 22:46 GMT
… assessing the heterogeneity of treatment effects.”
The researchers … randomized clinical trials of each glucose-lowering medication class.
… a four-arm trial included data from … (Byetta/Bydureon, AstraZeneca).
“Prior randomized clinical trials have …
-
Weight loss and diabetes drug comes from Utah Gila Monster spit
20 Oct 2025 18:41 GMT
… - The popular weight loss drugs Ozempic, Rybelsus and Wegovy have … as Byetta, which was approved in 2005 as a treatment for type … potential for use as a drug. Researchers discovered a unique hormone … has led to an important medical tool for humans."
There …
-
How a Chance Discovery Became the Basis for Today’s Biggest Blockbuster Weight Loss Drugs
08 Oct 2025 17:05 GMT
… FDA the previous year. By the time a doctor … Pharmaceuticals, the San Diego–based company that brought Byetta to market.
Yet Byetta … nonlethal venom-based medical treatment. An excellent example … drug continues. Eli Lilly is currently in Phase 3 clinical trials …
-
April - June 2025 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
30 Sep 2025 14:52 GMT
… secondary to a drug interaction with venlafaxine
FDA is evaluating …
Progressive multifocal leukoencephalopathy
FDA is evaluating the need for … (exenatide extended-release) injectable suspension
Byetta (exenatide) injection
Mounjaro (tirzepatide …
-
England's slimming jab NHS postcode lottery laid bare: Map shows how obese people in some areas are FIVE times more likely to be on drugs like Wegovy and Mounjaro - so do YOU live in a fat jab capital or desert?
25 Sep 2025 00:13 GMT
… include exenatide (Bydureon and Byetta), dulaglutide (Trulicity) and … #39;But as more drug treatments come online these should decline … not designed or tested.
Doctors have long told how … popular that the US pharmaceutical giant that manufactures Mounjaro …
-
FDA's green list cracks down on illegal imported drug ingredients
05 Sep 2025 22:51 GMT
… GLP-1 drugs, some of which are older medications, include Adlyxin, Byetta, Bydureon … FDA has approved certain GLP-1 drugs, including semaglutide and tirzepatide, for medical … is their product.
Previously, the FDA identified serious concerns about compound …
-
How Serena Williams’ admission of using a GLP-1 drug could impact the stigma of obesity
02 Sep 2025 22:15 GMT
… may shift obesity conversations, though treatment requires a holistic approach, … weight to consider GLP-1 treatments.
“She could be a … -1?
Without knowing her medical history, Reid says it … The first GLP-1 drug, Exenatide (brand name Byetta), was approved by …
-
January - March 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
29 Aug 2025 20:22 GMT
…
Bydureon (exenatide)
Bydureon BCise (exenatide)
Byetta (exenatide)
Ozempic (semaglutide)
Rybelsus (semaglutide … based on available information.
A FDA Drug Safety Communication was issued on … Information", and "Medication Guide" sections of the …
About
© 1995-2025